• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫学:涉及白细胞的反应:III. 抗甲状腺药物引起的粒细胞缺乏症。

Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs.

作者信息

Bilezikian S B, Laleli Y, Tsan M F, Hodkinson B A, Ice S, McIntyre P A

出版信息

Johns Hopkins Med J. 1976 Apr;138(4):124-9.

PMID:58084
Abstract

A method has previously been described which detected xenogeneic and allogeneic antibodies to human granulocytes by their inhibition of the normal phagocytosis-associated hexose monophosphate shunt (HMS) activity. This method was used to study three patients with acute agranulocytosis secondary to antithyroid drug administration. Two patients with methimazole and one patient with propylthiouracil induced agranulocytosis were studied. Serum samples from each of these three patients taken during the acute phase of agranulocytosis had inhibitory effects on phagocytosis-associated HMS activity in leukocytes from both normal donors and the patients after their full recovery from agranulocytosis. IgM but not IgG prepared from acute sera in two patients was also inhibitory. Disruption of IgM disulfide bonds by dithiothreitol destroyed its inhibitory activity. The possibility of drug-dependent immune destruction of leukocytes in these patients is discussed.

摘要

此前已描述了一种方法,该方法通过抑制正常的吞噬相关己糖磷酸分流(HMS)活性来检测针对人粒细胞的异种和同种异体抗体。该方法用于研究3例抗甲状腺药物所致急性粒细胞缺乏症患者。研究了2例因甲巯咪唑和1例因丙硫氧嘧啶诱发粒细胞缺乏症的患者。这3例患者在粒细胞缺乏症急性期采集的血清样本,对正常供者以及粒细胞缺乏症完全康复后的患者白细胞的吞噬相关HMS活性均有抑制作用。2例患者急性期血清制备的IgM具有抑制作用,而IgG则无。二硫苏糖醇破坏IgM二硫键后,其抑制活性消失。文中讨论了这些患者白细胞药物依赖性免疫破坏的可能性。

相似文献

1
Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs.免疫学:涉及白细胞的反应:III. 抗甲状腺药物引起的粒细胞缺乏症。
Johns Hopkins Med J. 1976 Apr;138(4):124-9.
2
[Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].[抗甲状腺药物致粒细胞缺乏症18例回顾性分析]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Jun;20(3):226-9.
3
Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.粒细胞缺乏症作为抗甲状腺药物在第二疗程或后续疗程中不良反应的特征。
Thyroid. 2014 May;24(5):796-801. doi: 10.1089/thy.2013.0476. Epub 2014 Jan 29.
4
Antithyroid drugs.抗甲状腺药物
N Engl J Med. 2005 Mar 3;352(9):905-17. doi: 10.1056/NEJMra042972.
5
[Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].[抗甲状腺药物所致粒细胞缺乏症。一种罕见但可怕的病症]
Lakartidningen. 2009;106(41):2607-8, 2610-1.
6
Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.粒细胞集落刺激因子治疗抗甲状腺药物所致粒细胞减少症
Arch Intern Med. 1993 Feb 22;153(4):509-14.
7
Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.日本 30 多年来抗甲状腺药物致粒细胞缺乏症 754 例分析。
J Clin Endocrinol Metab. 2013 Dec;98(12):4776-83. doi: 10.1210/jc.2013-2569. Epub 2013 Sep 20.
8
[Fever due to antithyroid agents].[抗甲状腺药物所致发热]
Ned Tijdschr Geneeskd. 1999 Jan 30;143(5):225-8.
9
In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.格雷夫斯病患者对丙硫氧嘧啶、甲巯咪唑和卡比马唑的体外免疫反应性:抗甲状腺药物所致粒细胞缺乏症的一个可能原因。
J Clin Endocrinol Metab. 1984 May;58(5):868-72. doi: 10.1210/jcem-58-5-868.
10
Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.抗甲状腺药物引起的血液系统损伤:一项涉及 50385 例格雷夫斯病患者的粒细胞缺乏症和全血细胞减少症的回顾性队列研究。
J Clin Endocrinol Metab. 2012 Jan;97(1):E49-53. doi: 10.1210/jc.2011-2221. Epub 2011 Nov 2.

引用本文的文献

1
Periodic Granulocyte Count Measuring Is Useful for Detecting Asymptomatic Agranulocytosis in Antithyroid Drug-Treated Patients with Graves' Disease.定期粒细胞计数测量有助于检测接受抗甲状腺药物治疗的格雷夫斯病患者的无症状粒细胞缺乏症。
Eur Thyroid J. 2016 Dec;5(4):253-260. doi: 10.1159/000448586. Epub 2016 Sep 6.
2
Does propylthiouracil increase the gentamicin-induced nephrotoxicity in rat?丙硫氧嘧啶是否会增加庆大霉素诱导的大鼠肾毒性?
Iran J Basic Med Sci. 2013 Nov;16(11):1190-5.
3
Propylthiouracil-induced hepatotoxicity.丙硫氧嘧啶所致肝毒性
West J Med. 1996 Sep;165(3):144-7.
4
Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.抗甲状腺药物所致粒细胞缺乏症:一家机构对10例患者的临床治疗经验及文献综述
J Endocrinol Invest. 1994 Jan;17(1):29-36. doi: 10.1007/BF03344959.
5
Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms.药物性再生障碍性贫血和粒细胞缺乏症。发病率及机制。
Drugs. 1986 Jan;31(1):52-63. doi: 10.2165/00003495-198631010-00004.
6
Adverse immunologic effects of antithyroid drugs.抗甲状腺药物的不良免疫效应。
CMAJ. 1987 Jan 15;136(2):121-7.
7
Drug-induced agranulocytosis.药物性粒细胞缺乏症
Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):449-62. doi: 10.1007/BF03259896.
8
Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study.抗甲状腺药物使用相关的粒细胞缺乏症和再生障碍性贫血风险。国际粒细胞缺乏症和再生障碍性贫血研究。
BMJ. 1988 Jul 23;297(6643):262-5. doi: 10.1136/bmj.297.6643.262.